tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ICPT

Intercept announces new findings from long-term extension of POISE trial
The FlyIntercept announces new findings from long-term extension of POISE trial
5M ago
ICPT
Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.
PremiumPress Releases
Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.
5M ago
ICPT
Alfasigma completes acquisition of Intercept
PremiumThe Fly
Alfasigma completes acquisition of Intercept
5M ago
ICPT
CHMP starts review of Intercept’s Ocaliva
PremiumThe Fly
CHMP starts review of Intercept’s Ocaliva
6M ago
ICPT
Intercept management to meet with Oppenheimer
PremiumThe Fly
Intercept management to meet with Oppenheimer
6M ago
ICPT
Intercept management to meet with Oppenheimer
PremiumThe FlyIntercept management to meet with Oppenheimer
6M ago
ICPT
Intercept management to meet with Oppenheimer
PremiumThe Fly
Intercept management to meet with Oppenheimer
6M ago
ICPT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
ACST
ADIL
Intercept price target raised to $19 from $12 at RBC Capital
PremiumThe Fly
Intercept price target raised to $19 from $12 at RBC Capital
7M ago
ICPT
Intercept price target raised to $19 from $11 at TD Cowen
PremiumThe Fly
Intercept price target raised to $19 from $11 at TD Cowen
7M ago
ICPT
Intercept downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Intercept downgraded to Neutral from Buy at H.C. Wainwright
7M ago
ICPT
Intercept downgraded to Hold from Buy at Canaccord
PremiumThe Fly
Intercept downgraded to Hold from Buy at Canaccord
7M ago
ICPT
Intercept downgraded to Neutral from Buy at B. Riley
PremiumThe FlyIntercept downgraded to Neutral from Buy at B. Riley
7M ago
ICPT
Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 per Share in Cash, Expanding the Global Footprint of Alfasigma Via a Leader in Rare and Serious Liver Diseases
PremiumPress Releases
Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 per Share in Cash, Expanding the Global Footprint of Alfasigma Via a Leader in Rare and Serious Liver Diseases
7M ago
ICPT
Alfasigma to acquire Intercept for $19.00 per share in cash
PremiumThe Fly
Alfasigma to acquire Intercept for $19.00 per share in cash
7M ago
ICPT
Intercept price target raised to $20 from $18 at Canaccord
PremiumThe Fly
Intercept price target raised to $20 from $18 at Canaccord
9M ago
ICPT
Intercept raises FY23 Ocaliva net sales view to $320M-$340M from $310M-$340M
PremiumThe Fly
Intercept raises FY23 Ocaliva net sales view to $320M-$340M from $310M-$340M
9M ago
ICPT
Intercept reports Q2 EPS (14c), consensus (51c)
PremiumThe Fly
Intercept reports Q2 EPS (14c), consensus (51c)
9M ago
ICPT
Intercept Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Updates
PremiumPress Releases
Intercept Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Updates
9M ago
ICPT
Oppenheimer biotechnology analyst to hold an analyst/industry conference call
PremiumThe FlyOppenheimer biotechnology analyst to hold an analyst/industry conference call
9M ago
CBAY
GNFT
Oppenheimer biotechnology analyst to hold an analyst/industry conference call
PremiumThe Fly
Oppenheimer biotechnology analyst to hold an analyst/industry conference call
9M ago
CBAY
GNFT
Oppenheimer biotechnology analyst to hold an analyst/industry conference call
PremiumThe Fly
Oppenheimer biotechnology analyst to hold an analyst/industry conference call
9M ago
CBAY
GNFT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >